Real-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real)

NCT06802848 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

1000

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis
Psoriatic Arthritis
Scalp Psoriasis
Nail Psoriasis
Palmoplantar Psoriasis
Genital Psoriasis

Interventions

DRUG: Xeligekimab injection

Sponsor

Chongqing Genrix Biopharmaceutical Co., Ltd

Collaborators

[object Object]